C

Cryo-Cell International Inc
AMEX:CCEL

Watchlist Manager
Cryo-Cell International Inc
AMEX:CCEL
Watchlist
Price: 8.35 USD 0.6% Market Closed
Market Cap: 67.3m USD
Have any thoughts about
Cryo-Cell International Inc?
Write Note

Cryo-Cell International Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cryo-Cell International Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
C
Cryo-Cell International Inc
AMEX:CCEL
Cash from Operating Activities
$7.2m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
19%
DaVita Inc
NYSE:DVA
Cash from Operating Activities
$2B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cash from Operating Activities
$1.4B
CAGR 3-Years
-15%
CAGR 5-Years
3%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Cash from Operating Activities
$4.6B
CAGR 3-Years
-36%
CAGR 5-Years
-18%
CAGR 10-Years
-3%
Cigna Corp
NYSE:CI
Cash from Operating Activities
$6.6B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
12%
Laboratory Corporation of America Holdings
NYSE:LH
Cash from Operating Activities
$1.4B
CAGR 3-Years
-24%
CAGR 5-Years
0%
CAGR 10-Years
6%
No Stocks Found

Cryo-Cell International Inc
Glance View

Market Cap
67.3m USD
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

CCEL Intrinsic Value
5.83 USD
Overvaluation 30%
Intrinsic Value
Price
C

See Also

What is Cryo-Cell International Inc's Cash from Operating Activities?
Cash from Operating Activities
7.2m USD

Based on the financial report for Aug 31, 2024, Cryo-Cell International Inc's Cash from Operating Activities amounts to 7.2m USD.

What is Cryo-Cell International Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%

Over the last year, the Cash from Operating Activities growth was -10%. The average annual Cash from Operating Activities growth rates for Cryo-Cell International Inc have been -8% over the past three years , 4% over the past five years , and 19% over the past ten years .

Back to Top